![](/img/cover-not-exists.png)
CYP2B6 genotype, but not rifampicin-based anti-TB cotreatments, explains variability in long-term efavirenz plasma exposure
Mukonzo, Jackson K, Nanzigu, Sarah, Waako, Paul, Ogwal-Okeng, Jasper, Gustafson, Lars L, Aklillu, EleniVolume:
15
Language:
english
Journal:
Pharmacogenomics
DOI:
10.2217/pgs.14.73
Date:
August, 2014
File:
PDF, 1.21 MB
english, 2014